The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.
Subcutaneous daratumumab is well tolerated, but ongoing immune monitoring is key to managing infection risk in patients with ...
SurvivorNet on MSN
FDA Approves New Subcutaneous (Under-the-Skin) Option for Keytruda: What It Means for Cancer Patients
The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option ...
The new formulation allows for subcutaneous delivery instead of intravenous administration of pembrolizumab for multiple ...
Merck's Keytruda Qlex offers a groundbreaking subcutaneous cancer treatment, enhancing patient convenience with faster ...
The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of lecanemab (Leqembi Iqlik) for weekly maintenance dosing to treat Alzheimer’s ...
The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately to severely ...
The Chosun Ilbo on MSN
Keytruda Subcutaneous Formulation Receives FDA Approval
The first immune checkpoint inhibitor that can be administered via a subcutaneous injection in just 1 to 2 minutes has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback